Low dose naltrexone for induction of remission in Crohn's disease-Reference-Cited by-同舟云学术

Low dose naltrexone for induction of remission in Crohn's disease

Published:2018-04-01 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Parker Claire E¹,Nguyen Tran M²,Segal Dan³,MacDonald John K²,Chande Nilesh⁴

Affiliation:

1. Robarts Clinical Trials; 100 Dundas Street, Suite 200 London ON Canada N6A 5B6

2. Robarts Clinical Trials; Cochrane IBD Group; 100 Dundas Street, Suite 200 London ON Canada

3. London Health Sciences Centre - University Hospital; 339 Windermere Road London ON Canada N6A 5A5

4. London Health Sciences Centre - Victoria Hospital; Room E6-321A 800 Commissioners Road East London ON Canada N6A 5W9

Publisher

Wiley

Subject

Pharmacology (medical)

Reference33 articles.

1. Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomized placebo-controlled trial;Smith;Digestive Diseases and Sciences,2011

2. Naltrexone therapy improves activity and promotes mucosal healing in active Crohn's disease: A placebo-controlled trial;Smith;Gastroenterology,2010

3. Safety and Tolerability of Low-dose Naltrexone Therapy in Children With Moderate to Severe Crohn's Disease: A Pilot Study;Smith;Journal of Clinical Gastroenterology,2013

4. Safety and efficacy of naltrexone therapy in children with moderate to severe Crohn's disease: Pilot study;Smith;Gastroenterology,2012

5. Apparent efficacy and safety of low dose naltrexone in Australian patients with active Crohn's disease;Jackson;Journal of Gastroenterology and Hepatology,2013

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Complexities of Long COVID;Viruses;2024-06-30

2. Low-dose naltrexone for post-COVID fatigue syndrome: a study protocol for a double-blind, randomised trial in British Columbia;BMJ Open;2024-05

3. Efficacy and Safety of Low Dose Naltrexone for Chronic Pain;Journal of Pain & Palliative Care Pharmacotherapy;2024-01-02

4. Low-dose naltrexone’s utility for non-cancer centralized pain conditions: a scoping review;Pain Medicine;2023-06-11

5. Low-dose naltrexone for treatment of burning mouth syndrome;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2023-04